New ultrasound ‘Helmet’ can treat Parkinson’s disease
(MENAFN) A new ultrasound “helmet” could offer a groundbreaking, non-invasive approach to treating Parkinson’s disease, according to recent research.
The study, published in Nature Communications, highlighted that "the newly developed system can reach brain regions 30 times smaller than conventional deep-brain devices," offering a level of precision previously unattainable, as reported.
The device is capable of targeting specific areas of the brain with up to 1,000 times greater accuracy than standard ultrasound, presenting a potential alternative to deep brain stimulation (DBS) for neurological disorders. Researchers believe it could also improve treatment for conditions such as Tourette syndrome, chronic pain, depression, and Alzheimer’s disease.
DBS is an invasive procedure involving the implantation of electrodes into targeted brain regions, which deliver controlled electrical pulses to modulate abnormal activity and relieve symptoms. In contrast, the new helmet removes the need for surgical intervention.
In trials, researchers successfully directed ultrasound waves to the lateral geniculate nucleus, demonstrating the device’s precision and effectiveness in reaching targeted brain regions.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
